Your browser doesn't support javascript.
loading
Transient loss of Polycomb components induces an epigenetic cancer fate.
Parreno, V; Loubiere, V; Schuettengruber, B; Fritsch, L; Rawal, C C; Erokhin, M; Gyorffy, B; Normanno, D; Di Stefano, M; Moreaux, J; Butova, N L; Chiolo, I; Chetverina, D; Martinez, A-M; Cavalli, G.
Afiliação
  • Parreno V; Institute of Human Genetics, CNRS, University of Montpellier, Montpellier, France.
  • Loubiere V; Institute of Human Genetics, CNRS, University of Montpellier, Montpellier, France.
  • Schuettengruber B; Research Institute of Molecular Pathology, Vienna BioCenter, Vienna, Austria.
  • Fritsch L; Institute of Human Genetics, CNRS, University of Montpellier, Montpellier, France.
  • Rawal CC; Institute of Human Genetics, CNRS, University of Montpellier, Montpellier, France.
  • Erokhin M; University of Southern California, Los Angeles, CA, USA.
  • Gyorffy B; Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.
  • Normanno D; Semmelweis University Department of Bioinformatics, Budapest, Hungary.
  • Di Stefano M; Department of Biophysics, Medical School, University of Pécs, Pécs, Hungary.
  • Moreaux J; Institute of Human Genetics, CNRS, University of Montpellier, Montpellier, France.
  • Butova NL; Institute of Human Genetics, CNRS, University of Montpellier, Montpellier, France.
  • Chiolo I; Institute of Human Genetics, CNRS, University of Montpellier, Montpellier, France.
  • Chetverina D; Department of Biological Hematology, CHU Montpellier, Montpellier, France.
  • Martinez AM; UFR Medicine, University of Montpellier, Montpellier, France.
  • Cavalli G; University of Southern California, Los Angeles, CA, USA.
Nature ; 629(8012): 688-696, 2024 May.
Article em En | MEDLINE | ID: mdl-38658752
ABSTRACT
Although cancer initiation and progression are generally associated with the accumulation of somatic mutations1,2, substantial epigenomic alterations underlie many aspects of tumorigenesis and cancer susceptibility3-6, suggesting that genetic mechanisms might not be the only drivers of malignant transformation7. However, whether purely non-genetic mechanisms are sufficient to initiate tumorigenesis irrespective of mutations has been unknown. Here, we show that a transient perturbation of transcriptional silencing mediated by Polycomb group proteins is sufficient to induce an irreversible switch to a cancer cell fate in Drosophila. This is linked to the irreversible derepression of genes that can drive tumorigenesis, including members of the JAK-STAT signalling pathway and zfh1, the fly homologue of the ZEB1 oncogene, whose aberrant activation is required for Polycomb perturbation-induced tumorigenesis. These data show that a reversible depletion of Polycomb proteins can induce cancer in the absence of driver mutations, suggesting that tumours can emerge through epigenetic dysregulation leading to inheritance of altered cell fates.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transformação Celular Neoplásica / Proteínas de Drosophila / Epigênese Genética / Drosophila melanogaster / Proteínas do Grupo Polycomb / Neoplasias Limite: Animals Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transformação Celular Neoplásica / Proteínas de Drosophila / Epigênese Genética / Drosophila melanogaster / Proteínas do Grupo Polycomb / Neoplasias Limite: Animals Idioma: En Ano de publicação: 2024 Tipo de documento: Article